1. 116PA targeted genomic analysis uncovered a large spectrum of acquired resistance mechanisms to BRAF inhibitor therapy in metastatic melanoma patients. (5th March 2018) Authors: Louveau, B; Reger de Moura, C; Battistella, M; Sadoux, A; Chami, I; Caramel, J; Dalle, S; Dumaz, N; Lebbe, C; Mourah, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1249PDConcomitant radiotherapy in melanoma brain metastases using the propensity score matching within the French cohort, MelBase. (23rd October 2018) Authors: Allayous, C; Oriano, B; Dalle, S; Mortier, L; Leccia, M-T; Guillot, B; Jeudy, G; Dutriaux, C; Lacour, J-P; Saiag, P; Brunet-Possenti, F; De Quatrebarbes, J; Stoebner, P-E; Legoupil, D; Beylot-Barry, M; Lesimple, T; Aubin, F; Ballon, A; Porcher, R; Lebbe, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1260PAn open-label, non-randomized, phase IIIb study of trametinib in combination with dabrafenib for patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma. (23rd October 2018) Authors: Saiag, P; Robert, C; Grob, J J; Mortier, L; Dereure, O; Lebbe, C; Mansard, S; Grange, F; Neidhardt, E-M; Lesimple, T; Machet, L; Bedane, C; Jeudy, G; Aubin, F; Dreno, B; Szenik, A; Denden, A; Dutriaux, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1560PDMajor determinants of delayed access to innovative medicines for metastatic melanoma: The results of Melanoma World Society and European Association of Dermato-Oncology survey. (23rd October 2018) Authors: Kandolf Sekulovic, L O; Agarwala, S S; Hauschild, A; Guo, J; McArthur, G A; Lorigan, P; Cinat, G; Caglevich, C; Lebbe, C; Rutkowski, P L; Gogas, H; Dummer, R; Neyns, B; Bastholt, L; Wainstein, A; Herceg, D; Banjin, M; Zhukavets, A; Ocvirk, J; Garbe, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 182TiPEXPRESS study: A multicenter, prospective trial in progress exploring the association between low level of genomic alteration and exceptional and unexpected response to targeted therapies in patients with solid tumors. (23rd October 2018) Authors: Italiano, A; Le Saux, O; André, F; Filleron, T; Spaeth, D; Heudel, P-E; Albiges, L; Bachelot, T; Gonçalves, A; Pierga, J-Y; Barlesi, F; Boige, V; Lebbe, C; Mortier, L; Frenel, J-S; Tredan, O; Jimenez, M; Legrand, F; Ferté, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Aphthous ulcers in HIV-infected patients: treatment with thalidomide. Issue 6 (December 1992) Authors: Strazzi, S; Lebbe, C; Geoffray, C; Ablon, G; Morel, P; Verola, O; Molina, J M Journal: Sexually transmitted infections Issue: Volume 68:Issue 6(1992) Page Start: 424 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study. (13th August 2019) Authors: Long, G V; Flaherty, K T; Stroyakovskiy, D; Gogas, H; Levchenko, E; de Braud, F; Larkin, J; Garbe, C; Jouary, T; Hauschild, A; Chiarion-Sileni, V; Lebbe, C; Mandalá, M; Millward, M; Arance, A; Bondarenko, I; Haanen, J B A G; Hansson, J; Utikal, J; Ferraresi, V Journal: Annals of oncology Issue: Volume 30:Number 11(2019) Page Start: 1848 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Intraindividual variability of the bioavailability of low dose methotrexate after oral administration in rheumatoid arthritis. Issue 7 (July 1994) Authors: Lebbe, C; Beyeler, C; Gerber, N J; Reichen, J Journal: Annals of the rheumatic diseases Issue: Volume 53:Issue 7(1994) Page Start: 475 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure. Issue 2 (2nd February 2004) Authors: Matichard, E; Verpillat, P; Meziani, R; Gérard, B; Descamps, V; Legroux, E; Burnouf, M; Bertrand, G; Bouscarat, F; Archimbaud, A; Picard, C; Ollivaud, L; Basset-Seguin, N; Kerob, D; Lanternier, G; Lebbe, C; Crickx, B; Grandchamp, B; Soufir, N Journal: Journal of medical genetics Issue: Volume 41:Issue 2(2004) Page Start: e13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P05.76 Resuming treatment with immune checkpoint inhibitors in cancer patients who developed immune-related meningitis. (19th September 2018) Authors: Cuzzubbo, S; Ursu, R; Mazoyer, J; Belin, C; Baroudjian, B; Lebbe, C; Carpentier, A Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗